KR20170004041A - Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction - Google Patents
Antioxidant or anti-aging composition comprising lettuce flower extract or its fractionInfo
- Publication number
- KR20170004041A KR20170004041A KR1020170000113A KR20170000113A KR20170004041A KR 20170004041 A KR20170004041 A KR 20170004041A KR 1020170000113 A KR1020170000113 A KR 1020170000113A KR 20170000113 A KR20170000113 A KR 20170000113A KR 20170004041 A KR20170004041 A KR 20170004041A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- fraction
- lettuce
- antioxidant
- present
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 68
- 235000003228 Lactuca sativa Nutrition 0.000 title claims abstract description 63
- 241000208822 Lactuca Species 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 41
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 39
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000013305 food Nutrition 0.000 claims abstract description 23
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 230000000694 effects Effects 0.000 claims abstract description 16
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000002904 solvent Substances 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 14
- 239000000469 ethanolic extract Substances 0.000 claims description 14
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 239000002034 butanolic fraction Substances 0.000 claims description 8
- 239000002038 ethyl acetate fraction Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 230000002292 Radical scavenging effect Effects 0.000 abstract description 20
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 15
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 10
- 229930003935 flavonoid Natural products 0.000 abstract description 9
- 150000002215 flavonoids Chemical class 0.000 abstract description 9
- 235000017173 flavonoids Nutrition 0.000 abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 8
- 235000013824 polyphenols Nutrition 0.000 abstract description 8
- 230000007760 free radical scavenging Effects 0.000 abstract description 7
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 abstract description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 34
- 238000004519 manufacturing process Methods 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 13
- 230000036541 health Effects 0.000 description 12
- 240000008415 Lactuca sativa Species 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000002775 capsule Substances 0.000 description 7
- 235000013376 functional food Nutrition 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- -1 (butylated hydroxy anisol Chemical compound 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 229940093499 ethyl acetate Drugs 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000002044 hexane fraction Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 2
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000002036 chloroform fraction Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 239000012457 nonaqueous media Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- IITIZHOBOIBGBW-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole Chemical compound C1=CC=C2N(CC)CSC2=C1 IITIZHOBOIBGBW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 항산화 또는 항노화용 조성물에 관한 것으로, 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 약학적 조성물, 화장료 조성물, 및 식품에 관한 것이다.
The present invention relates to a composition for antioxidant or anti-aging, and relates to a pharmaceutical composition for antioxidant or anti-aging, a cosmetic composition, and a food containing an extract of lettuce or a fraction thereof as an active ingredient.
공기 중에 일반적으로 존재하는 안정한 분자상태인 기저 삼중항산소가 체내 효소계, 환원대사, 화학약품, 공해물질, 광화학 반응과 같은 환경 및 생화학적 요인 등에 의하여 반응성이 매우 큰 자유라디칼(free radical)인 활성산소(active oxygen)로 전환되어 세포의 구성성분을 비가역적으로 파괴한다.The basic tritiated oxygen, which is a stable molecular state generally present in the air, is a free radical which is highly reactive due to environmental and biochemical factors such as in vivo enzymes, reducing metabolism, chemicals, pollutants, It is converted to active oxygen and irreversibly destroys cellular components.
활성산소는 체내 방어기구인 수퍼옥사이드 디스뮤타제(superoxide dismutase, SOD), 카탈라아제(catalase), 퍼옥시다아제(peroxidase), 글루타치온(glutathione) 등의 항산화성 효소 및 비타민 C(vitamin C, ascorbic acid), 비타민 E(tocopherol) 등의 항산화 물질의 작용에 의하여 최소화 될 수 있다. 하지만 과도한 활성산소에 노출되거나 생체 방어력에 이상이 생기게 될 경우 균형이 깨어져서 활성산소가 생체에 치명적인 산소독성을 일으키게 된다.The active oxygen is an antioxidant enzyme such as superoxide dismutase (SOD), catalase, peroxidase, glutathione, vitamin C, ascorbic acid, vitamin E (tocopherol) and the like can be minimized by the action of antioxidants. However, when exposed to excessively active oxygen or defective bio-defense, the balance is broken and active oxygen causes lethal oxygen toxicity to the living body.
체내 과도한 활성산소는 세포구성 성분들인 지질, 단백질, 당, DNA 등과 반응하여 파괴작용을 함으로써 노화는 물론 암을 비롯하여 뇌졸중, 파킨슨씨병 등의 뇌질환과 심장질환, 허혈, 동맥경화, 피부손상, 염증, 류마티스, 자가면역질환 등의 각종 질병을 일으키는 원인이 되고 있다. Excessively active oxygen in the body reacts with cellular components such as lipids, proteins, sugars, and DNA to destroy it, thereby causing aging, brain diseases such as cancer, stroke and Parkinson's disease, heart disease, ischemia, atherosclerosis, , Rheumatism, autoimmune diseases, and the like.
이와 같은 산화적 스트레스가 노화를 비롯하여 각종 질환을 일으키는 중요한 원인임이 밝혀지면서 생체 내 활성산소를 제거하는 항산화제를 개발하려는 연구가 활발히 진행되고 있다. As such oxidative stress is found to be an important cause of various diseases including aging, researches are actively conducted to develop antioxidants that remove active oxygen in vivo.
합성 항산화제로 널리 사용되고 있는 BHA(butylated hydroxy anisol)와 BHT(butylated hydroxy toluene)는 그 효과와 경제성 그리고 안전성 때문에 많이 사용해 왔지만 합성 첨가물의 일반적인 기피 현상뿐만 아니라 장기간 과량 복용 시 위장점막, 폐, 신장, 순환계 등에 심각한 독성작용을 일으키는 것으로 알려져 그 사용량이 법적으로 규제되어 있다.BHA (butylated hydroxy anisol) and BHT (butylated hydroxy toluene), which are widely used as synthetic antioxidants, have been widely used because of their effectiveness, economical efficiency and safety. However, not only general avoidance phenomena of synthetic additives but also gastrointestinal mucosa, lung, And it is known that it causes serious toxic effects on the environment and its usage is legally regulated.
또한 인체에 무해하고 항산화력이 우수한 천연 항산화제 관한 연구가 오래전부터 진행되어 왔으나 토코페롤과 같은 천연 항산화제는 인체에 대하여 안전하기는 하나 단독으로는 산화 연쇄반응 저지 능력이 있고, 가격이 비싼 단점이 있다. Natural antioxidants, which are harmless to human body and have excellent antioxidant power, have been studied for a long time. However, natural antioxidants such as tocopherol are safe for human body, but they have the ability to inhibit oxidative chain reaction and have a disadvantage of high price have.
따라서 보다 안전하고 항산화 효능이 탁월하면서도 경제성이 있는 새로운 항산화제 개발이 절실히 요구되어 진다.Therefore, it is urgently required to develop a new antioxidant which is safer, has excellent antioxidant efficacy, and is economical.
상추(Lactuca sativa)는 국화과에 속하는 1년생과 2년생의 초본식물로 유럽 및 서아시아 원산의 재배식물이다. 상추의 다른 이름은 와거(식료본초), 와거채(부후비급방), 천금채(청이록), 와순(전남본초), 와채(본초강목), 등채(하북약재), 부루, 상치, 엽채 등으로 부른다. 줄기는 곧게 서고 반들반들하며 털이 없고, 어릴 때는 죽순처럼 막대기 모양으로 키는 1미터까지 자라고 가지가 많이 갈라진다. 잎은 주로 식용하며, 잎의 가장자리는 밋밋하거나 주름지고 또는 불규칙한 톱니 모양의 결각이 있고 자루가 없다. 꽃은 6~7월에 노란색으로 피는데, 꽃은 양성이고 모두 혀모양 꽃이다. 수술은 5개이고 씨방은 밑에 있고 암술머리는 2개로 갈라진다. 꽃이 진 뒤에 작은 수과는 달걀모양이고 편평하며 3개의 돌출된 세로 모서리가 있고 흑갈색 또는 회백색이다.Lettuce ( Lactuca sativa ) is a first and second year herbaceous plant belonging to the Asteraceae family, and is cultivated in Europe and West Asia. The other names of lettuce are Wagar (food prime herb), Rajeong (Buhui Ward room), Chunggwangchae (Chungil Rock), Wassoon (Chonnam Chongmok), Wajae . The stem is straight, smooth and hairless, and grows up to 1 meter tall as a stick like a bamboo shoot when it is young, and branches are split a lot. The leaves are mainly edible, and the edges of the leaves are flat, wrinkled, or irregular serrated, with no sacks. Flowers bloom from June to July in yellow, flowers are positive and all are tongue-shaped flowers. There are 5 stamens, the ovary is on the bottom, and the stigma is divided into two. After the flowering, the small aquifers are oval and flat, with three protruding vertical edges and dark brown or grayish white.
상추의 잎, 줄기, 및 씨는 고혈압, 소변불리, 혈뇨, 유즙불통, 스트레스 해소, 소화촉진, 숙취해소, 입냄새 제거, 치아미백 등에 효능이 있는 것으로 알려져 있으며, 상추꽃에 대한 효능은 명확히 알려진 바가 없다.Leaf, stems and seeds of lettuce are known to be effective for hypertension, urinary discomfort, hematuria, insufficient milking, relieving stress, promoting digestion, relieving hangovers, deodorizing, teeth whitening, etc. The efficacy of lettuce flowers is well known There is no bar.
한편, 한국등록특허 제826,902호는 한방 발효액의 제조방법으로 상추꽃을 선택적으로 포함할 수 있다는 기재만 있을 뿐 상추꽃 자체에 대한 효능이나 상추꽃을 포함하여 제조된 한방 발효액에 대한 효능은 기재하고 있지 않다.On the other hand, Korean Patent No. 826,902 discloses that it is possible to selectively contain lettuce flowers as a method of manufacturing a herbal fermentation broth, and describes the efficacy of the lettuce flower itself or the efficacy of the herbal fermentation broth including lettuce flowers It is not.
이처럼 상추꽃에 대한 효능은 구체적으로 밝혀진 바가 없으며, 더욱이 상추꽃 추출물 또는 이의 분획물의 항산화 효과는 알려져 있지 않다.Thus, the effect on the lettuce flower has not been elucidated in detail, and the antioxidative effect of the lettuce flower extract or its fraction is not known.
이에 본 발명자들은 연구를 거듭하는 과정에서, 상추꽃 추출물 및 이의 분획물이 유해 활성산소(free radical) 제거하고, 제2철염을 감소(Ferric reducing/antioxidant power, FRAP) 시키는 활성이 있다는 것을 실험을 통해 최초로 규명하였다. 따라서 천연물 유래로 안전한 상추꽃 추출물 및 이의 분획물을 항산화 조성물로 활용할 수 있는 바, 본 발명을 완성하기에 이르렀다.
Accordingly, the inventors of the present invention have experimentally found that the lettuce flower extract and its fractions have an activity of removing free radicals and reducing ferric reducing / antioxidant power (FRAP) First. Therefore, a safe extract of lettuce and its fractions derived from natural materials can be used as an antioxidant composition, and thus the present invention has been completed.
본 발명의 목적은 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 약학적 조성물, 화장료 조성물, 및 식품을 제공하는 것이다.
It is an object of the present invention to provide a pharmaceutical composition for antioxidant or anti-aging, a cosmetic composition, and a food containing an extract of lettuce or a fraction thereof as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 상추꽃 추출물 또는 이의 분획물이 폴리페놀 및 플라보노이드의 함량이 높고, 자유라디칼(free radical) 제거 및 제2철 감소(Ferric reducing/antioxidant power, FRAP) 활성 또한 높다는 것을 실험을 통해 확인함으로써 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 약학적 조성물, 화장료 조성물, 및 식품을 제공한다.
In order to achieve the above object, the present invention provides a plant extract or a fraction thereof having a high content of polyphenols and flavonoids, a free radical elimination and a ferric reducing / antioxidant power (FRAP) The present invention provides an antioxidant or anti-aging pharmaceutical composition, a cosmetic composition, and a food containing the lettuce flower extract or a fraction thereof as an active ingredient.
본 발명의 상추꽃 추출물 또는 이의 분획물은 폴리페놀 및 플라보노이드 함량이 높고, DPPH(2,2-diphenyl-1-picryl-hydrazyl) 자유라디칼 소거, ABTS(2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate)) 라디칼 소거, 하이드록시(Hydroxy) 라디칼 소거, 수퍼옥사이드(Superoxide) 라디칼 소거, 및 제2철 감소(Ferric reducing/antioxidant power, FRAP)에서 높은 활성을 나타낸다는 것을 확인하였으므로 상추꽃 추출물 또는 이의 분획물은 항산화 또는 항노화용 약학적 조성물, 화장료 조성물, 및 식품의 유효성분으로 유용하게 사용될 수 있다.
The extract of Lettuce or its fraction of the present invention has a high content of polyphenols and flavonoids and is free from DPPH (2,2-diphenyl-1-picryl-hydrazyl) free radical scavenging, ABTS (2,2'-azino-bis -6-sulfonate) radical scavenging, hydroxyl radical scavenging, superoxide radical scavenging, and ferric reducing / antioxidant power (FRAP) The extract or its fractions can be usefully used as an active ingredient in pharmaceutical compositions, cosmetic compositions, and foods for antioxidant or anti-aging purposes.
도 1은 상추꽃 추출물과 분획물의 제조과정을 나타낸 것이다.Figure 1 shows the process for the production of lettuce flower extract and fractions.
본 발명은 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 약학적 조성물에 관한 것이다.
The present invention relates to a pharmaceutical composition for antioxidant or anti-aging comprising an extract of lettuce or a fraction thereof as an active ingredient.
본 발명의 일 양태에서, 상기 상추꽃 추출물 및 이의 분획물은 하기 단계들을 포함하는 제조방법에 의해 제조될 수 있다.In one aspect of the present invention, the lettuce flower extract and its fractions can be produced by a manufacturing method comprising the following steps.
a) 상추꽃에 추출용매를 가하여 추출하는 단계;a) extracting lettuce flowers with an extraction solvent;
b) 상기 a) 단계의 추출물을 여과하는 단계;b) filtering the extract of step a);
c) 상기 단계 b)의 여과한 추출물을 감압 농축한 후 건조하여 상추꽃 추출물을 제조하는 단계; 및c) extracting the filtered extract of step b) and concentrating it under reduced pressure, followed by drying to produce an extract of lettuce; And
d) 상기 c) 단계에서 수득된 상추꽃 추출물에 헥산, 클로로포름, 에틸 아세테이트, 부탄올을 순차적으로 가해 용매의 극성에 따라 분별(계통) 분리를 진행하여 분리된 각각의 용매 추출물을 감압 농축하여 용매를 제거한 후 동결 건조시켜 분획물을 제조하는 단계.d) The lettuce flower extract obtained in step c) is sequentially subjected to fractionation (systematic separation) according to the polarity of the solvent by adding hexane, chloroform, ethyl acetate and butanol sequentially, and each of the separated solvent extracts is concentrated under reduced pressure to obtain a solvent And then lyophilized to prepare a fraction.
본 발명의 일 양태에서, 상기 제조방법에 있어 a)단계의 상추꽃은 재배한 것 또는 시판되는 것 등 제한 없이 사용할 있다.In one embodiment of the present invention, the lettuce flower of step a) may be cultivated or commercially available.
본 발명의 일 양태에서, 상기 제조방법에 있어 a) 단계의 추출용매는 물, 알코올, 또는 이들이 혼합물을 사용하는 것이 바람직하다.In one embodiment of the present invention, it is preferable that the extraction solvent of step (a) is water, an alcohol, or a mixture thereof.
본 발명의 일 양태에서, 상기 제조방법에 있어 알코올은 C1 내지 C2 저급 알코올일 수 있으며, 바람직하게 에탄올 또는 메탄올일 수 있으며, 보다 더 바람직하게는 70% 에탄올일 수 있다.In one embodiment of the present invention, the alcohol in the preparation process may be a C 1 to C 2 lower alcohol, preferably ethanol or methanol, and even more preferably 70% ethanol.
본 발명의 일 양태에서, 상기 제조방법에 있어 추출온도는 50 내지 100 ℃인 것이 바람직하고, 추출시간은 5 내지 24 시간인 것이 바람직하며, 아울러 추출횟수는 1 내지 5회 반복 추출하는 것이 바람직하다.
In one embodiment of the present invention, the extraction temperature is preferably 50 to 100 ° C., the extraction time is preferably 5 to 24 hours, and the extraction frequency is preferably 1 to 5 times .
본 발명의 일 양태에서, 상기 약학적 조성물은 유해 활성산소(free radical) 제거 및 제2철염 감소(Ferric reducing/antioxidant power, FRAP) 중 적어도 하나 이상의 활성을 가진다.In one embodiment of the present invention, the pharmaceutical composition has at least one activity of removing harmful free radicals and decreasing ferric reducing / antioxidant power (FRAP).
본 발명의 일 양태에서, 상기 약학적 조성물은 DPPH(2,2-diphenyl-1-picryl-hydrazyl) 자유라디칼 소거, ABTS(2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate)) 라디칼 소거, 하이드록시(Hydroxy) 라디칼 소거, 수퍼옥사이드(Superoxide) 라디칼 소거, 및 제2철 감소(Ferric reducing/antioxidant power, FRAP)로 이루어진 군으로부터 선택되는 하나 이상의 활성을 가진다.In one aspect of the invention, the pharmaceutical composition comprises DPPH (2,2-diphenyl-1-picryl-hydrazyl) free radical scavenging, ABTS (2,2'-azino-bis (3- ethylbenzothiazoline- Wherein the enzyme has at least one activity selected from the group consisting of radical scavenging, hydroxyl radical scavenging, superoxide radical scavenging, and ferric reducing / antioxidant power (FRAP).
상기 본 발명의 약학적 조성물은 약학적으로 허용 가능한 담체를 포함할 수 있다. 약학적으로 허용 가능한 담체를 포함하는 상기 조성물은 경구 또는 비경구의 여러 가지 제형일 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 하나 이상의 화합물에 적어도 하나 이상의 부형제 예를 들면, 전분, 탄산칼슘, 수크로스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 스테아린산 마그네슘, 탈크 등과 같은 윤활제들도 사용될 수 있다. 경구투여를 위한 액상제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수성용제, 현탁용제로는 프로필렌 글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween)61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.The pharmaceutical composition of the present invention may comprise a pharmaceutically acceptable carrier. The composition comprising a pharmaceutically acceptable carrier can be of various oral or parenteral formulations. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain one or more excipients such as starch, calcium carbonate, sucrose or lactose, gelatin, . In addition to simple excipients, lubricants such as magnesium stearate, talc, and the like may also be used. Liquid preparations for oral administration include suspensions, solutions, emulsions, syrups and the like. Various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included in addition to water and liquid paraffin, which are simple diluents commonly used. have. Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used as the non-aqueous solvent and suspension agent. Examples of the suppository base include witepsol, macrogol, tween 61, cacao paper, laurin, glycerogelatin and the like.
상기 약학적 조성물은 정제, 환제, 산제, 과립제, 캡슐제, 현탁제, 내용액제, 유제, 시럽제, 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제 및 좌제로 이루어진 군으로부터 선택되는 어느 하나의 제형을 가질 수 있다.The pharmaceutical composition may be in the form of tablets, pills, powders, granules, capsules, suspensions, solutions, emulsions, syrups, sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, lyophilized preparations and suppositories It can have one formulation.
상기 본 발명의 약학적 조성물은 약학적으로 유효한 양으로 투여한다. The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount.
본 발명에서 용어 "약학적으로 유효한 양”은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효 용량 수준은 개체 종류 및 중증도, 연령, 성별, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료 기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 상추꽃 추출물 또는 분획물은 1일 1 내지 100 mg/kg으로, 바람직하게는 1 내지 10 mg/kg으로 투여될 수 있다.The term "pharmaceutically effective amount " as used herein means an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment, and the effective dose level will vary depending on the species and severity, age, sex, , The sensitivity to the drug, the time of administration, the route of administration and the rate of excretion, the duration of the treatment, factors including co-administered drugs, and other factors well known in the medical arts. The extract or fraction may be administered at a daily dose of 1 to 100 mg / kg, preferably 1 to 10 mg / kg.
본 발명의 조성물은 개별 치료제로 투여하거나 항산화 효과 또는 항노화 효과를 나타내는 다른 치료제와 병용하여 투여될 수 있고, 종래의 치료제와 순차적 또는 동시에 투여될 수 있다. 그리고 단일 또는 다중 투여될 수 있다. 상기 요소를 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 당업자에 의해 용이하게 결정될 수 있다.The composition of the present invention may be administered as an individual therapeutic agent or in combination with another therapeutic agent exhibiting an antioxidative or anti-aging effect, and may be administered sequentially or simultaneously with a conventional therapeutic agent. And can be administered singly or multiply. It is important to take into account all of the above factors and to administer the amount in which the maximum effect can be obtained in a minimal amount without adverse effect, and can be easily determined by those skilled in the art.
본 발명에서 용어 "개체”란 항산화 효과 또는 항노화 활성을 통해 예방 또는 치료할 수 있는 질환이 이미 발병되었거나, 발병될 수 있는 인간을 포함한 모든 동물을 의미하고 본 발명의 추출물 또는 분획물을 포함하는 조성물을 개체에게 투여함으로써, 상기 질환을 효과적으로 예방 및 치료할 수 있다. In the present invention, the term "individual " means all animals, including humans, who have already developed or are capable of developing a disease that can be prevented or treated through antioxidative or anti-aging activity, and include a composition comprising the extract or fraction of the present invention By administering to an individual, the disease can be effectively prevented and treated.
상기 약학적 조성물의 투여 경로는 목적 조직에 도달할 수 있는 한 어떠한 일반적인 경로를 통하여 투여될 수 있다. 본 발명의 조성물은 목적하는 바에 따라 복강내 투여, 정맥내 투여, 근육내 투여, 피하 투여, 피내 투여, 경구 투여, 비내 투여, 폐내 투여, 직장내 투여될 수 있으나, 이에 제한되지는 않는다. 또한 상기 조성물은 활성 물질이 표적 세포로 이동할 수 있는 임의의 장치에 의해 투여될 수 있다.
The route of administration of the pharmaceutical composition may be administered through any conventional route so long as it can reach the target tissue. The composition of the present invention may be administered intraperitoneally, intravenously, intramuscularly, subcutaneously, intradermally, orally, intranasally, intrapulmonarily, or rectally, though it is not intended to be limited thereto. The composition may also be administered by any device capable of transferring the active agent to the target cell.
본 발명은 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 화장료 조성물에 관한 것이다.The present invention relates to an antioxidant or anti-aging cosmetic composition containing an extract of lettuce or a fraction thereof as an active ingredient.
본 발명의 일 양태에서, 상기 화장료 조성물의 상추꽃 추출물은 물, C1 내지 C2의 저급 알코올 또는 이들의 혼합물을 용매로 사용하여 추출한 추출물일 수 있고, 보다 바람직하게는 물 및 에탄올의 혼합물을 용매로 사용하여 추출한 추출물일 수 있으며, 보다 더 바람직하게는 70% 에탄올을 사용하여 추출한 추출물일 수 있다.In one embodiment of the present invention, the lettuce flower extract of the cosmetic composition may be an extract obtained by using water, a C 1 to C 2 lower alcohol or a mixture thereof as a solvent, more preferably a mixture of water and ethanol It may be an extract that is extracted using a solvent, and more preferably, it is an extract that is extracted using 70% ethanol.
본 발명의 일 양태에서, 상기 화장료 조성물은 유해 활성산소(free radical) 제거 및 제2철염 감소(Ferric reducing/antioxidant power, FRAP) 중 적어도 하나 이상의 활성을 가진다.In one embodiment of the present invention, the cosmetic composition has at least one activity of removing harmful free radicals and decreasing ferric reducing / antioxidant power (FRAP).
발명의 일 양태에서, 상기 화장료 조성물은 DPPH(2,2-diphenyl-1-picryl-hydrazyl) 자유라디칼 소거, ABTS(2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate)) 라디칼 소거, 하이드록시(Hydroxy) 라디칼 소거, 수퍼옥사이드(Superoxide) 라디칼 소거, 및 제2철 감소(Ferric reducing/antioxidant power, FRAP)로 이루어진 군으로부터 선택되는 하나 이상의 활성을 가진다.In one aspect of the invention, the cosmetic composition comprises a radical scavenging DPPH (2,2-diphenyl-1-picryl-hydrazyl) radical, ABTS (2,2'-azino-bis (3-ethylbenzothiazoline- , Hydroxy radical scavenging, Superoxide radical scavenging, and Ferric reducing / antioxidant power (FRAP).
상기 화장료 조성물은 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition may be in the form of, for example, a solution, a gel, a solid or a paste anhydrous product, an emulsion obtained by dispersing an oil phase in water, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome) In the form of a cream, a skin, a lotion, a powder, an ointment, a spray or a cone stick. It can also be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한 상기 화장료 조성물은 상추꽃 추출물 또는 이의 분획물에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition may further contain, in addition to the extract of lettuce or its fraction, a lipid, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, Water, ionic or non-ionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics Such as, for example, cosmetics, cosmetics, pharmaceuticals, cosmetics, pharmaceuticals,
본 발명의 상추꽃 추출물 또는 이의 분획물을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 상추꽃 추출물 또는 이의 분획물은 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다. In the cosmetic composition containing the lettuce flower extract or the fraction thereof of the present invention, the lettuce flower extract or the fraction thereof of the present invention is added to the cosmetic composition usually contained in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight .
본 발명의 상추꽃 추출물 또는 이의 분획물을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.
When the lettuce flower extract or the fraction thereof of the present invention is used as an external preparation for skin, it may further contain a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, A preservative, a vitamin, a barrier, a wetting agent, a essential oil, a dye, a pigment, a hydrophilic or lipophilic active agent, a lipid vesicle or An adjuvant commonly used in the field of dermatology, such as any other ingredient conventionally used in external preparations for skin. In addition, the components can be introduced in amounts commonly used in the dermatology field.
본 발명은 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 식품에 관한 것이다.The present invention relates to an antioxidant or anti-aging food containing an extract of lettuce or a fraction thereof as an active ingredient.
본 발명의 일 양태에서, 상기 식품의 상추꽃 추출물 또는 이의 분획물은 물, C1 내지 C2의 저급 알코올 또는 이들의 혼합물을 용매로 사용하여 추출한 추출물일 수 있고, 보다 바람직하게는 물 및 에탄올의 혼합물을 용매로 사용하여 추출한 추출물일 수 있으며, 보다 더 바람직하게는 70% 에탄올을 사용하여 추출한 추출물일 수 있다.In one embodiment of the present invention, the lettuce flower extract or fraction thereof of the food may be an extract obtained by using water, a C 1 to C 2 lower alcohol or a mixture thereof as a solvent, more preferably water and ethanol The extract may be an extract obtained by using the mixture as a solvent, and more preferably an extract obtained by using 70% ethanol.
본 발명의 일 양태에서, 상기 식품은 유해 활성산소(free radical) 제거 및 제2철염 감소(Ferric reducing/antioxidant power, FRAP) 중 적어도 하나 이상의 활성을 가진다.In one aspect of the present invention, the food has at least one activity of removing harmful free radicals and reducing ferric reducing / antioxidant power (FRAP).
발명의 일 양태에서, 상기 식품은 DPPH(2,2-diphenyl-1-picryl-hydrazyl) 자유라디칼 소거, ABTS(2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate)) 라디칼 소거, 하이드록시(Hydroxy) 라디칼 소거, 수퍼옥사이드(Superoxide) 라디칼 소거, 및 제2철 감소(Ferric reducing/antioxidant power, FRAP)로 이루어진 군으로부터 선택되는 하나 이상의 활성을 가진다.In one aspect of the invention, the food product comprises a DPPH (2,2-diphenyl-1-picryl-hydrazyl) free radical scavenger, an ABTS (2,2'-azino- At least one activity selected from the group consisting of Hydroxy radical scavenging, Superoxide radical scavenging, and Ferric reducing / antioxidant power (FRAP).
본 발명에 따른 식품은, 상추꽃 추출물 또는 이의 분획물을 포함하되 적절한 식품보조첨가제가 포함될 수 있다.The food according to the present invention may include an extract of lettuce or a fraction thereof, and suitable food supplementary additives.
본 발명에서 용어 "식품보조첨가제”란 식품에 보조적으로 첨가될 수 있는 구성요소를 의미하며, 각 제형의 건강기능식품을 제조하는데 첨가되는 것으로서 당업자가 적절히 선택하여 사용할 수 있다. 식품보조첨가제의 예로는 여러 가지 영양제, 비타민, 광물 (전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 충진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등이 포함되지만, 상기 예들에 의해 본 발명의 식품보조첨가제의 종류가 제한되는 것은 아니다.The term "food-aid additive " in the present invention means a component which can be added to foods in a supplementary manner, and it can be appropriately selected and used by those skilled in the art as being added to produce health functional foods of each formulation. A coloring agent and a filler, a pectic acid and a salt thereof, an alginic acid and a salt thereof, an organic acid, a protective colloid thickener, a pH adjuster, a stabilizer, a stabilizer and a stabilizer such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, A preservative, a glycerin, an alcohol, a carbonating agent used in a carbonated drink, etc. However, the types of the food-aid additive of the present invention are not limited by the above examples.
본 발명의 일 양태에서, 상기 식품은 건강기능식품일 수 있다.In one aspect of the invention, the food may be a health functional food.
본 발명에서 용어 "건강기능식품”이란 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 정제, 캅셀, 분말, 과립, 액상 및 환 등의 형태로 제조 및 가공한 식품을 말한다. 여기서 기능성이라 함은 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건용도에 유용한 효과를 얻는 것을 의미한다. 본 발명의 건강기능식품은 당업계에서 통상적으로 사용되는 방법에 의하여 제조가능하며, 상기 제조 시에는 당업계에서 통상적으로 첨가하는 원료 및 성분을 첨가하여 제조할 수 있다. 또한 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있고, 휴대성이 뛰어나, 본 발명의 건강기능식품은 항산화 또는 항노화 효과를 증진시키기 위한 보조제로 섭취가 가능하다. The term "health functional food " in the present invention refers to a food prepared and processed in the form of tablets, capsules, powders, granules, liquids and rings by using raw materials and components having useful functions in the human body. The health functional food of the present invention can be prepared by a method commonly used in the art, and the health functional food of the present invention can be manufactured by the method Unlike general medicines, there is an advantage that there are no side effects that may occur when a drug is taken for a long time by using a food as a raw material, and the portability In addition, the health functional food of the present invention can be ingested as an adjuvant for enhancing antioxidant or anti-aging effect.
유효성분의 혼합양은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품의 제조 시에 본 발명에 따른 상추꽃 추출물 또는 이의 분획물은 원료 조성물 중 1 ~ 10 중량%, 바람직하게는 5 ~ 10 중량%의 양으로 첨가된다. 그러나 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하로도 사용될 수 있다.The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment). Generally, lettuce flower extract or a fraction thereof according to the present invention is added in an amount of 1 to 10% by weight, preferably 5 to 10% by weight, of the raw material composition when the food is prepared. However, in the case of long-term ingestion intended for health and hygiene purposes or for the purpose of controlling health, the amount can also be used in the above-mentioned range.
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the food to which the above substance can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which include healthy foods in a conventional sense.
본 발명의 건강식품에는 통상의 식품과 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유될 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 수크로스와 같은 디사카라이드 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 g당 일반적으로 약 0.1 ~ 10 g, 바람직하게는 약 0.01 ~ 0.1 g 이다.
The health food of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary foods. The above-mentioned natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and xylitol, sorbitol and erythritol. As the sweetening agent, natural sweetening agents such as tau Martin and stevia extract, synthetic sweetening agents such as saccharine and aspartame, and the like can be used. The ratio of the natural carbohydrate is generally about 0.1 to 10 g, preferably about 0.01 to 0.1 g per 100 g of the composition of the present invention.
이하, 하기 실시예, 실험예, 및 제조예를 통하여 본 발명에 대하여 보다 상세히 설명하고자 한다. 다만 이는 본 발명에 대한 이해를 돕기 위한 것이지, 본 발명의 권리범위를 이로 한정하려는 의도는 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples, experimental examples, and production examples. It should be understood, however, that the same is by way of illustration and example only and is not intended to limit the scope of the present invention.
[[ 실시예Example ] 시료의 추출 및 분획] Extraction and fractionation of sample
강원도 횡성에서 제공받은 상추꽃을 실온에서 건조시킨 후 중량의 10배인 70% 에탄올을 첨가하고 80 ℃에서 8시간 동안 3회 추출한 다음 뜨거운 상태에서 여과한 후 감압농축기를 사용하여 추출용매를 제거한 후 농축물을 얻어 상추꽃 70% 에탄올 추출물을 제조하였다.The lettuce flowers supplied from Hoengseong, Gangwon Province were dried at room temperature, and then 70% ethanol, which was 10 times the weight of the extract, was added. The extracts were extracted three times at 80 ° C for 8 hours. Then, the extracts were filtered using a hot condenser, Water was added to make a 70% ethanol extract of lettuce.
상기 상추꽃 70% 에탄올 추출물을 헥산, 클로로포름, 에틸 아세테이트, 및 부탄올 용매의 극성에 따라 순차적으로 분별(계통) 분리를 행하여 헥산, 클로로포름, 에틸 아세테이트, 부탄올 및 물층으로 극성의 차이에 의해 다섯 가지 분획으로 조제하였다. 분리된 각각의 용매 분획물은 감압농축하여 용매를 제거한 후 동결건조기로 건조시켜 제조하였다(도 1).
The 70% ethanol extract of lettuce flower was fractionated (systematically) sequentially according to the polarity of hexane, chloroform, ethyl acetate, and butanol solvent, and hexane, chloroform, ethyl acetate, butanol and water layer were separated into five fractions . Each of the separated solvent fractions was concentrated under reduced pressure to remove the solvent and dried by a freeze dryer (FIG. 1).
[[ 실험예Experimental Example ]]
○ 실험결과의 통계 처리○ Statistical processing of experimental results
실험을 통해 얻어진 자료는 SPSS 21.0(statistical package for the social science, Chicago, IL, USA) PC 패키지(package)를 이용하여 분석하였다. 결과는 평균±표준편차로 나타내었으며 실험군 간의 평균 값 차이는 일원배치분산분석(one-way ANOVA)을 한 후 던컨의 다중검정(Duncan’s multiple range test)에 의해 p<0.05수준에서 각 실험군 평균치 간에 유의성을 검증하였다.
The data obtained from the experiments were analyzed using a PC package (SPSS 21.0, statistical package for the social science, Chicago, IL, USA). The results were expressed as mean ± SD. The mean difference between the experimental groups was analyzed by one-way ANOVA followed by Duncan's multiple range test. Respectively.
실험예Experimental Example 1: 폴리페놀 및 플라보노이드 함량 측정 1: Determination of polyphenol and flavonoid content
총 폴리페놀 함량 측정을 위해 증류수로 용해한 시료 0.2 mL을 시험관에 넣고 증류수를 5 mL 첨가하여 혼합한 다음 실온에서 3분간 방치하였다. 그리고 10% Na2CO3 포화용액 1 mL을 가하여 혼합하고 실온에서 1시간 반응 시킨 후 상등액을 700 nm에서 흡광도를 측정하였다. 표준물질은 카페산(caffeic acid)을 0∼100 μg/mL의 농도로 제조하여 시료와 동일한 방법으로 분석하였으며, 표준검량곡선으로부터 추출물의 총 페놀함량을 계산하였다.To measure the total polyphenol content, 0.2 mL of the sample dissolved in distilled water was added to a test tube, 5 mL of distilled water was added, and the mixture was allowed to stand at room temperature for 3 minutes. Then, 1 mL of 10% Na 2 CO 3 saturated solution was added and reacted at room temperature for 1 hour. Absorbance of the supernatant was measured at 700 nm. Caffeic acid was prepared at a concentration of 0 to 100 μg / mL and analyzed by the same method as the sample. The total phenol content of the extract was calculated from the standard calibration curve.
총 플라보노이드는 추출물 0.5 mL에 10% 질산알루미늄(aluminum nitrate) 0.1 mL, 1 M 아세트산칼륨(potassium acetate) 0.1 mL 및 80% 에탄올(ethanol) 4.3 mL를 차례로 가하여 혼합하고 실온에서 40분간 방치한 다음 415 nm에서 흡광도를 측정하였다. 표준물질은 퀘르세틴(quercetin)을 0∼100 μg/mL의 농도로 제조하여 시료와 동일한 방법으로 분석하였으며, 표준검량곡선으로부터 추출물의 총 플라보노이드 함량을 계산하였다.Total flavonoid was prepared by adding 0.1 mL of 10% aluminum nitrate, 0.1 mL of 1 M potassium acetate and 4.3 mL of 80% ethanol to the 0.5 mL of the extract, mixing the mixture, incubating at room temperature for 40 minutes, nm absorbance was measured. The standard substance, quercetin, was prepared at a concentration of 0 to 100 μg / mL and analyzed in the same manner as the sample. The total flavonoid content of the extract was calculated from the standard calibration curves.
그 결과, 상추꽃 70% 에탄올 추출물의 총폴리페놀 및 플라보노이드 함량은 46.86±4.61 mg/g 및 42.81±2.06 mg/g를 나타내었다. 또한 부탄올 분획물의 총폴리페놀 함량은 177.81±10.28으 mg/g으로 상추꽃 70% 에탄올 추출물에 비해 증가하였으며 플라보노이드 함량 또한 170.27±1.61 mg/g으로 증가하여 높은 함량을 나타내었다. 특히, 에틸아세테이트 분획물의 총폴리페놀 함량은 298.37±7.55 mg/g으로 상추꽃 70% 에탄올 추출물에 비해 6배 정도 증가하였으며 플라보노이드 함량 또한 175.46±3.44 mg/g으로 4배 정도 증가하여 가장 높은 함량을 나타내었다(표 1).
As a result, total polyphenol and flavonoid contents of lettuce flower 70% ethanol extracts were 46.86 ± 4.61 mg / g and 42.81 ± 2.06 mg / g, respectively. The total polyphenol content of the butanol fraction was 177.81 ± 10.28 mg / g, which was higher than that of the 70% ethanol extract of lettuce flower and the content of flavonoid increased to 170.27 ± 1.61 mg / g. Especially, the total polyphenol content of the ethyl acetate fraction was 298.37 ± 7.55 mg / g, which was about 6 times higher than that of 70% ethanol extract of lettuce flower, and the flavonoid content was also 175.46 ± 3.44 mg / (Table 1).
실험예Experimental Example 2: 2: DPPHDPPH 자유라디칼Free radical 소거능Scatters
DPPH(2,2-diphenyl-1-picryl-hydrazyl) 자유라디칼 소거활성을 확인하기 위해 시료 희석액 0.4 mL에 1×10-4 M DPPH용액 5.6 mL를 첨가한 후, 10분간 방치하여 525 nm에서 흡광도를 측정하였다. DPPH 소거능은 시료 무 첨가군에 대한 첨가군의 흡광도 비로 나타내었다.In order to confirm the DPPH (2,2-diphenyl-1-picryl-hydrazyl) free radical scavenging activity, 5.6 mL of 1 × 10 -4 M DPPH solution was added to 0.4 mL of the sample dilution and left for 10 minutes. Were measured. The DPPH scavenging activity was expressed as the absorbance ratio of the addition group to the sample-free addition group.
그 결과, 70% 에탄올 추출물을 포함하여 모든 분획물의 DPPH 라디칼 소거활성은 농도 의존적으로 증가하였다. 특히, 1,000 μg/mL의 농도에서 70% 에탄올 추출물은 40.25±1.34%의 소거활성을 나타내었으며, 부탄올 분획물은 88.44±0.08%의 높은 소거활성을 나타내었고, 에틸 아세테이트 분획물의 경우에는 92.36±0.08%의 소거활성을 나타내어 70% 에탄올 추출물에 비해 2배 이상 증가한 가장 높은 소거활성을 나타내었다(표 2).
As a result, the DPPH radical scavenging activity of all fractions including the 70% ethanol extract increased in a concentration dependent manner. Especially, at the concentration of 1,000 μg / mL, the 70% ethanol extract showed a scavenging activity of 40.25 ± 1.34%, the butanol fraction showed a high scavenging activity of 88.44 ± 0.08%, the ethylacetate fraction showed 92.36 ± 0.08% (Table 2). In addition, the highest activity of the extracts was observed.
실험예Experimental Example 3: 3: ABTSABTS 자유라디칼Free radical 소거능Scatters
ABTS(2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) 자유라디칼 소거능을 확인하기 위해 ABTS 양이온 탈색 분석법(cation decolorization assay)에 따라 7.4 mM ABTS용액에 2,4 mM 과황산칼륨(potassium persulfate)을 넣고 암실에서 12 내지 16시간 동안 반응시켰다. 반응액을 734 nm에서 흡광도가 0.7이 되도록 증류수로 희석을 시킨 후 용액 2 mL에 시료용액 1 mL를 가하여 실온에서 10분간 반응시킨 다음 734 nm에서 흡광도를 측정하였다. ABTS 자유라디칼 소거능은 시료 첨가구와 무 첨가구의 흡광도 비로 나타내었다.To determine the free radical scavenging ability of 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonate), ABTS (cation decolorization assay) The reaction solution was diluted with distilled water to an absorbance of 0.7 at 734 nm, and then 1 mL of the sample solution was added to 2 mL of the solution, followed by reaction at room temperature for 10 minutes. Then, 734 nm The ABTS free radical scavenging activity was expressed as the absorbance ratio of the sample with and without the sample.
그 결과, 70% 에탄올 추출물을 포함하여 모든 분획물의 ABTS 라디칼 소거활성은 농도 의존적으로 증가하였다. 특히, 200 μg/mL의 농도에서 70% 에탄올 추출물은 57.73±0.75%의 소거활성을 나타내었으며, 부탄올 분획물의 경우에는 79.13±0.15%의 소거활성을 나타내었고, 에틸 아세테이트 분획물의 경우에는 85.59±0.30%의 소거활성을 나타내었다(표 3).
As a result, the ABTS radical scavenging activity of all fractions including the 70% ethanol extract increased in a concentration dependent manner. Especially, at the concentration of 200 μg / mL, the 70% ethanol extract showed an elimination activity of 57.73 ± 0.75%, the butanol fraction had an elimination activity of 79.13 ± 0.15%, and the ethyl acetate fraction had an activity of 85.59 ± 0.30 % Of the scavenging activity (Table 3).
실험예Experimental Example 4: 4: 하이드록시Hydroxy (( HydroxyHydroxy ) ) 라디칼Radical 소거능Scatters
하이드록시(Hydroxy) 라디칼 소거능을 확인하기 위해 10mM FeSO4·7H2O/EDTA 용액 0.2 mL, 10 mM 2-디옥시리보오스(2-deoxyribose) 0.2 mL, 농도별 시료액 0.2 mL, 0.1 M 인산나트륨 완충용액(sodium phosphate buffer) (pH 7.4) 1.2 mL 및 10 mM H2O2 0.2 mL를 차례로 가한 다음 37 ℃에서 1시간 반응시킨 후 10% TCA 용액 1 mL, 1% TBA 1 mL을 가하고 95 ℃ 수욕상에서 10분간 가열한 다음 급냉시킨 후 532 nm에서 흡광도를 측정하였다. 시료의 하이드록시 라디칼(hydroxyl radical) 소거능은 다음 식에 따라 계산하였다.
To confirm the hydroxyl radical scavenging ability, 0.2 mL of 10 mM FeSO 4 · 7H 2 O / EDTA solution, 0.2 mL of 10 mM 2-deoxyribose, 0.2 mL of sample solution per concentration, 0.1 M sodium phosphate buffer solution 1.2 mL of sodium phosphate buffer (pH 7.4) and 0.2 mL of 10 mM H 2 O 2 in that order, react at 37 ° C for 1 hour, add 1 mL of 10% TCA solution and 1 mL of 1% TBA, For 10 minutes, and then quenched, and the absorbance was measured at 532 nm. The hydroxyl radical scavenging ability of the sample was calculated according to the following equation.
그 결과, 헥산 분획물을 제외한 나머지 분획물은 농도 의존적으로 하이드록시 라디칼(hydroxy radical) 소거활성이 증가하였다. 특히 70% 에탄올 추출물은 5 mg/mL의 농도에서 29.70±2.19%의 소거능을 나타내었으며, 부탄올 분획물과 물층은 같은 농도에서 각각 41.35±0.32% 및 38.15±2.27%의 소거활성을 나타내었다(표 4). As a result, hydroxy radical scavenging activity was increased in the other fractions except for the hexane fraction in a concentration dependent manner. Particularly, the 70% ethanol extract showed a scavenging activity of 29.70 ± 2.19% at the concentration of 5 mg / mL, and the butanol fraction and the water layer showed the scavenging activity at the same concentration of 41.35 ± 0.32% and 38.15 ± 2.27% ).
실험예Experimental Example 5: 5: 수퍼옥사이드Superoxide (( SuperoxideSuperoxide ) ) 라디칼Radical 소거능Scatters
수퍼옥사이드(Superoxide) 라디칼 소거능을 확인하기 위해 시료를 농도별로 조제 후 24-웰 플레이트에 각각 0.5 mL씩 넣고, 30 mM 트리스-염화수소 완충액(tris-HCl buffer)(pH 8.0) 0.1 mL, 0.1 mM 페나진 메토설페이트(phenazine methosulfate, PMS) 0.2 mL, 0.5 mM 니트로테트라졸리움 블루 클로라이드(nitrotetrazolium blue chloride, NBT) 0.2mL 및 0.5 mM 니코틴 아미드 아데닌 디뉴클레오티드(nicotinamide adenine dinucleotide, NADH) 0.4 mL를 넣었다. 실온에서 10분간 반응시킨 다음 560 nm에서 흡광도를 측정하였다.To confirm the superoxide radical scavenging ability, each sample was added at a concentration of 0.5 mL into a 24-well plate, and 0.1 mL of 30 mM tris-HCl buffer (pH 8.0), 0.1 mM phenanthrene 0.2 mL of phenazine methosulfate (PMS), 0.2 mL of 0.5 mM nitrotetrazolium blue chloride (NBT), and 0.4 mL of 0.5 mM nicotinamide adenine dinucleotide (NADH). After incubation at room temperature for 10 minutes, absorbance was measured at 560 nm.
그 결과, 70% 에탄올 추출물 및 분획물은 농도의존적으로 수퍼옥사이드 라디칼 소거활성이 증가하였으나 70% 에탄올 추출물, 헥산 분획물, 클로로포름 분획물 및 물층은 50% 이하의 소거활성을 나타내었다. 그러나 에틸아세테이트 분획물과 부탄올 분획물은 1,000 μg/mL의 농도에서 각각 53.00±0.64% 및 69.89±0.80%의 수퍼옥사이드 라디칼 소거활성을 나타내었다(표 5).
As a result, the 70% ethanol extract and fraction showed an increase in superoxide radical scavenging activity in a concentration dependent manner, but 70% ethanol extract, hexane fraction, chloroform fraction and water layer showed less than 50% scavenging activity. However, ethyl acetate fraction and butanol fraction showed superoxide radical scavenging activity of 53.00 ± 0.64% and 69.89 ± 0.80% at a concentration of 1,000 μg / mL, respectively (Table 5).
실험예 6: 제2철 감소(Ferric reducing/antioxidant power, FRAP ) 활성(환원력) Experimental Example 6: Ferric reducing / antioxidant power ( FRAP ) activity (reducing power)
제2철 감소 활성(Ferric reducing/antioxidant power, FRAP) 측정을 위해 제2철 감소 활성 시약(FRAP reagent)은 300 mM 아세트산 나트륨 완충액(sodium acetate buffer)(pH 3.6) 25 mL, 40 mM 염화수소(HCl)로 용해한 10 mM 2,4,6-트리스(2-피리딜)-s-트리아진(2,4,6-tris(2-pyridyl)-s-triazine, TPTZ) 2.5 mL, 20 mM 염화제이철(FeCl3) 2.5 mL, 및 증류수 3 mL를 섞은 혼합물로 제조하였다. 실험은 각각의 시료 0.05 mL에 상기 혼합물 1.5 mL를 가한 후 혼합하여 37 ℃에서 5분간 반응시킨 후 593 nm에서의 흡광도를 측정하였다. For ferric reducing / antioxidant power (FRAP) measurements, the ferric reducing agent (FRAP reagent) was dissolved in 25 mL of 300 mM sodium acetate buffer (pH 3.6), 40 mM HCl 2.5 mL of 10 mM 2,4,6-tris (2-pyridyl) -s-triazine (TPTZ) dissolved in 20 mM ferric chloride (FeCl 3 ), and 3 mL of distilled water. In the experiment, 0.05 mL of each sample was added to 1.5 mL of the mixture, and the mixture was reacted at 37 ° C. for 5 minutes, and the absorbance at 593 nm was measured.
그 결과, 상추꽃 70% 에탄올 추출물은 1,000 μg/mL의 농도에서 0.405±0.006의 흡광도를 나타내었다. 헥산 분획물, 클로로포름 분획물, 물층은 같은 농도에서 0.3 이하의 낮은 흡광도를 나타내었다. 반면에 에틸아세테이트 분획물과 부탄올 분획물은 같은 농도에서 각각 2.726±0.012와 1.381±0.010의 흡광도를 나타내었다(표 6). As a result, 70% ethanol extract of lettuce showed 0.405 ± 0.006 absorbance at a concentration of 1,000 μg / mL. The hexane fraction, chloroform fraction and water layer showed low absorbance of 0.3 or less at the same concentration. On the other hand, the ethyl acetate fraction and the butanol fraction exhibited an absorbance of 2.726 ± 0.012 and 1.381 ± 0.010, respectively, at the same concentration (Table 6).
[[ 제조예Manufacturing example ]]
제조예 1. 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 약학적 제제의 제조 Production Example 1. Preparation of antioxidant or anti-aging pharmaceutical preparation containing extract of lettuce or its fraction as an active ingredient
1-1. 1-1. 산제의Sanje 제조 Produce
상추꽃 추출물 또는 이의 분획물................... 500 mgLettuce flower extract or its fraction ... 500 mg
수크로스......................................... 100 mgSucrose ......................................... 100 mg
탈크............................................. 10 mgTalc ............................................. 10 mg
상기 성분들을 분말화하여 혼합한 후 기밀포에 충진하여 산제를 제조한다.
The above components are powdered and mixed, and filled in an airtight container to prepare a powder.
1-2. 정제의 제조1-2. Manufacture of tablets
상추꽃 추출물 또는 이의 분획물................... 100 mgLettuce flower extract or its fractions ................... 100 mg
유당............................................. 100 mgLactose ............................................. 100 mg
전분............................................. 100 mgStarch ............................................. 100 mg
스테아린산 마그네슘.............................. 2 mgMagnesium stearate .............................. 2 mg
상기의 성분을 혼합하고 통상의 정제의 제조 방법에 따라서 타정하여 정제를 제조한다.
The above components are mixed and tablets are prepared by tableting according to a conventional method for producing tablets.
1-3. 캡슐의 제조1-3. Manufacture of capsules
상추꽃 추출물 또는 이의 분획물................... 100 mgLettuce flower extract or its fractions ................... 100 mg
유당............................................. 100 mg
Lactose ............................................. 100 mg
전분............................................. 100 mgStarch ............................................. 100 mg
탈크............................................. 2 mgTalc ............................................. 2 mg
스테아린산마그네슘............................... 적량Magnesium stearate ................................ Amount
상기의 성분을 혼합하고 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조한다.
The above components are mixed and filled in gelatin capsules according to the conventional preparation method of capsules to prepare capsules.
1-4. 과립의 제조1-4. Manufacture of granules
상추꽃 추출물 또는 이의 분획물................... 150 mgLettuce flower extract or its fraction ... 150 mg
대두 추출물...................................... 50 mgSoybean extract ...................................... 50 mg
포도당........................................... 200 mgGlucose ........................................... 200 mg
전분............................................. 500 mgStarch ............................................. 500 mg
상기 성분들을 혼합한 후 30% 에탄올 100 mL를 첨가하여 60 ℃에서 건조시켜 과립을 형성한 후 포에 충진하여 과립제를 제조한다.
After mixing the above components, 100 mL of 30% ethanol is added, and the mixture is dried at 60 ° C to form granules, which are filled in a capsule to prepare granules.
1-5. 1-5. 환제의Pennant 제조 Produce
상추꽃 추출물 또는 이의 분획물................... 20 mgLettuce flower extract or fraction thereof 20 mg
유당............................................. 1,500 mgLactose ............................................. 1,500 mg
글리세린......................................... 1,500 mgGlycerin ......................................... 1,500 mg
전분............................................. 980 mgStarch ............................................. 980 mg
상기 성분들을 혼합한 후 통상의 환제의 제조방법에 따라 1환 당 4 g이 되도록 제조한다.
After mixing the above components, they are prepared so as to be 4 g per one ring according to a conventional method for producing a pellet.
1-6. 1-6. 액제의Liquid 제조 Produce
상추꽃 추출물 또는 이의 분획물................... 100 mgLettuce flower extract or its fractions ................... 100 mg
설탕............................................. 20 gSugar ............................................. 20 g
이성화당......................................... 20 gIs isomerization ......................................... 20 g
레몬향........................................... 적량Lemon flavor ............................................
정제수를 가하여 전체............................. 100 mlAdd purified water to the whole ............................. 100 ml
상기의 성분을 통상의 액제의 제조방법에 따라서 혼합하고 100 ml의 갈색병에 충전하고 멸균시켜서 액제를 제조한다.
The above components are mixed according to a conventional method for preparing a liquid preparation, filled in a 100 ml brown bottle, and sterilized to prepare a liquid preparation.
1-7. 주사제의 제조1-7. Injection preparation
상추꽃 추출물 또는 이의 분획물................... 0.1 mgLettuce flower extract or fraction thereof 0.1 mg
소디움 메타비설파이트............................ 0.5 mgSodium Metabisulfite ............................ 0.5 mg
메틸파라벤....................................... 0.8 mgMethylparaben ....................................... 0.8 mg
프로필파라벤..................................... 0.1 mgPropylparaben ..................................... 0.1 mg
주사용 멸균증류수................................ 적량Sterile sterilized water for injection ................................
상기의 성분을 혼합하고 통상의 방법으로 3 ml로 한 후, 3 ml 용량의 앰플에 충전하고 멸균하여 주사제를 제조한다.
The above ingredients are mixed and made into 3 ml by a conventional method, and then filled into a 3 ml capacity ampoule and sterilized to prepare an injection.
제조예 2. 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 화장료의 제조 Production Example 2. Preparation of antioxidant or anti-aging cosmetic containing extract of lettuce or fraction thereof as an active ingredient
2-1. 유연 화장수의 제조2-1. Production of flexible lotion
상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 유연 화장수는 하기 표 7과 같이 제조한다.A soft lotion containing extract of lettuce or a fraction thereof as an active ingredient is prepared as shown in Table 7 below.
2-2. 영양 크림의 제조2-2. Manufacture of nutrition cream
상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 영양크림은 하기 표 8과 같이 제조한다.The nutritional cream containing the lettuce flower extract or its fraction as an active ingredient is prepared as shown in Table 8 below.
제조예 3. 상추꽃 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 식품의 제조 Production Example 3. Preparation of antioxidant or anti-aging food containing extract of lettuce or its fraction as an active ingredient
3-1. 밀가루 식품의 제조3-1. Manufacture of flour food products
상추꽃 추출물 또는 이의 분획물 0.5 내지 5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조한다.
0.5 to 5.0 parts by weight of lettuce flower extract or its fractions are added to wheat flour, and the mixture is used to prepare breads, cakes, cookies, crackers and noodles.
3-2. 3-2. 스프soup 및 육즙의 제조 And juices
상추꽃 추출물 또는 이의 분획물 0.1 내지 5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조한다.
0.1 to 5.0 parts by weight of lettuce flower extract or its fractions are added to the soup and juice to prepare a health improvement meat product, noodle soup and juice.
3-3. 유제품의 제조3-3. Manufacture of dairy products
상추꽃 추출물 또는 이의 분획물 5 내지 10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.
5 to 10 parts by weight of lettuce flower extract or its fractions were added to milk, and the milk was used to prepare various dairy products such as butter and ice cream.
3-4. 건강기능 식품의 제조3-4. Manufacture of Health Functional Foods
상추꽃 추출물 또는 이의 분획물 20 ㎎, 비타민 혼합물 적량, 비타민 A 아세테이트 70 ㎍, 비타민 E 1.0 ㎎, 비타민 B1 0.13 ㎎, 비타민 B2 0.15 ㎎, 비타민 B6 0.5 ㎎, 비타민 B12 0.2 ㎍, 비타민 C 10 ㎎, 비오틴 10 ㎍, 니코틴산아미드 1.7 ㎎, 엽산 50 ㎍, 판토텐산 칼슘 0.5 ㎎, 무기질 혼합물 적량, 황산제 1철 1.75 ㎎, 산화아연 0.82 ㎎, 탄산마그네슘 25.3 ㎎, 제1인산칼륨 15 ㎎, 제2인산칼슘 55 ㎎, 구연산칼륨 90 ㎎, 탄산칼슘 100 ㎎, 염화마그네슘 24.8 ㎎을 혼합하여 통상의 건강식품 제조방법에 따라 제조한다.
A vitamin A acetate, 70 mg of vitamin A, 1.0 mg of vitamin E, 0.13 mg of vitamin B1, 0.15 mg of vitamin B2, 0.5 mg of vitamin B6, 0.2 mg of vitamin B12, 10 mg of vitamin C, 10 mg of nicotinic acid amide, 1.7 mg of nicotinic acid amide, 50 mg of folic acid, 0.5 mg of calcium pantothenate, 1.75 mg of ferrous sulfate, 0.82 mg of zinc oxide, 25.3 mg of magnesium carbonate, 15 mg of potassium phosphate monobasic Mg, potassium citrate (90 mg), calcium carbonate (100 mg) and magnesium chloride (24.8 mg) are mixed and prepared according to a conventional method for preparing healthy foods.
3-5. 건강 음료의 제조3-5. Manufacture of health drinks
상추꽃 추출물 또는 이의 분획물 20 ㎎, 구연산 1000 ㎎, 올리고당 100 g, 매실농축액 2 g, 타우린 1 g, 정제수 적량을 혼합하여 통상의 건강 음료의 제조방법에 따라 제조한다.
The extract is prepared by mixing 20 mg of the extract of Lettuce or its fraction, 1000 mg of citric acid, 100 g of oligosaccharide, 2 g of a plum concentrate, 1 g of taurine and an appropriate amount of purified water.
Claims (5)
A pharmaceutical composition for skin aging comprising an butanol or an ethyl acetate fraction of an extract obtained by extracting lettuce flowers with water, C 1 to C 2 lower alcohols or a mixture thereof as a solvent.
상추꽃 추출물은 70% 에탄올 추출물을 사용하여 추출한 추출물인 것을 특징으로 하는, 항피부노화용 약학적 조성물.
The method according to claim 1,
Wherein the lettuce flower extract is an extract obtained by using a 70% ethanol extract.
상기 약학적 조성물은 유해 활성산소(free radical) 제거 및 제2철염 감소(Ferric reducing/antioxidant power, FRAP) 중 적어도 하나 이상의 활성을 나타내는 것을 특징으로 하는, 항피부노화용 약학적 조성물.
The method according to claim 1,
Wherein the pharmaceutical composition exhibits at least one activity of removing harmful free radicals and reducing ferric reducing / antioxidant power (FRAP).
A cosmetic composition for antioxidant or anti-aging use wherein the lettuce flower is a butanol or ethyl acetate fraction of an extract which is extracted with water, a C 1 to C 2 lower alcohol or a mixture thereof as a solvent as an active ingredient.
An anti-aging food comprising an butanol or ethyl acetate fraction of an extract obtained by extracting lettuce flowers with water, a C 1 to C 2 lower alcohol or a mixture thereof as a solvent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170000113A KR101806220B1 (en) | 2017-01-02 | 2017-01-02 | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170000113A KR101806220B1 (en) | 2017-01-02 | 2017-01-02 | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140143986A Division KR20160047732A (en) | 2014-10-23 | 2014-10-23 | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170004041A true KR20170004041A (en) | 2017-01-10 |
KR101806220B1 KR101806220B1 (en) | 2017-12-07 |
Family
ID=57811937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170000113A KR101806220B1 (en) | 2017-01-02 | 2017-01-02 | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101806220B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190137257A (en) | 2018-06-01 | 2019-12-11 | 재단법인 경북바이오산업연구원 | Anti-inflammatory composition comprising the extracts of lettuce |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100826902B1 (en) | 2006-01-04 | 2008-05-06 | 박미숙 | Manufacturing method for a fermented functional traditional oriental medicine |
-
2017
- 2017-01-02 KR KR1020170000113A patent/KR101806220B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100826902B1 (en) | 2006-01-04 | 2008-05-06 | 박미숙 | Manufacturing method for a fermented functional traditional oriental medicine |
Also Published As
Publication number | Publication date |
---|---|
KR101806220B1 (en) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009126863A (en) | Composition highly containing ergothioneine extracted from mushroom | |
KR102306737B1 (en) | Antioxidant food comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR20170100977A (en) | Antioxidant composition comprising fermented extract of ilex paraguayensis, houttuynia cordata, illicium verum and undaria pinnatifida and manufacturing method thereof | |
KR101611853B1 (en) | Aster glehni fractions or compounds isolated therefrom having anti-inflammatory activity | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR101806220B1 (en) | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction | |
KR20200089040A (en) | Composition for preventing, improving or treating cancer comprising Abeliophyllum distichum extract as effective component | |
KR101447007B1 (en) | Composition for antiaging comprising the extract of Dipterocarpus obtusifolius Teijsm. Ex Miq. as an active ingredient | |
KR20170059221A (en) | Antioxidant or anti-aging composition comprising the extract of stem and leaf of Rubus coreanus Miquel | |
JP7016510B2 (en) | Blood cholesterol elevation inhibitory composition | |
JP2005089374A (en) | Food and drink having function for preventing increase in blood glucose level | |
JP2017165686A (en) | Liver function improver | |
KR20160047732A (en) | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction | |
JP2019182863A (en) | Skin firmness or moisture improving composition | |
KR101622032B1 (en) | Pharmaceutical composition comprising Cymbidium extract for preventing or treating muscle atrophy | |
JP7320270B2 (en) | Liver function improver | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
JP2014141437A (en) | Learning memory improving agent | |
KR101425047B1 (en) | Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient | |
JP7271017B2 (en) | Composition for suppressing elevation of blood cholesterol | |
KR102273578B1 (en) | Antioxidant composition comprising epigallocatechin gallate as effective gradient and method for preparing the same | |
JP7562169B2 (en) | Composition for suppressing elevation of blood cholesterol | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR102129461B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR101440483B1 (en) | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |